Menu Search
Equities

Gritstone bio Inc

2JQ:FRA

Gritstone bio Inc

Actions
  • Price (EUR)0.0013
  • Today's Change0.000 / 8.33%
  • Shares traded65.09k
  • 1 Year change-99.92%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 19:17 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Gritstone bio Inc's revenues fell -18.05% from 19.95m to 16.34m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 119.69m to a larger loss of 138.49m.
Gross margin--
Net profit margin-910.50%
Operating margin-933.98%
Return on assets-72.86%
Return on equity-201.94%
Return on investment-83.37%
More ▼

Cash flow in USDView more

In 2023, Gritstone bio Inc increased its cash reserves by 8.97%, or 5.81m. Cash Flow from Investing totalled 102.34m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 121.65m for operations while cash generated from financing totalled 25.12m.
Cash flow per share-1.20
Price/Cash flow per share--
Book value per share0.1884
Tangible book value per share0.1884
More ▼

Balance sheet in USDView more

Gritstone bio Inc has a Debt to Total Capital ratio of 64.61%, a higher figure than the previous year's 27.13%.
Current ratio2.54
Quick ratio--
Total debt/total equity1.83
Total debt/total capital0.6461
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.